News
Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.
Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...
A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results